A new head-to-head study of tirzepatide versus semaglutide for weight loss in people living with obesity, but not diabetes, shows that over 72 weeks tirzepatide results in an average weight loss of 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback